[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FI101222B1 - Menetelmä terapeuttisesti aktiivisten kinolin-2-yylimetoksifenyylijohdannaisten valmistamiseksi - Google Patents

Menetelmä terapeuttisesti aktiivisten kinolin-2-yylimetoksifenyylijohdannaisten valmistamiseksi

Info

Publication number
FI101222B1
FI101222B1 FI923841A FI923841A FI101222B1 FI 101222 B1 FI101222 B1 FI 101222B1 FI 923841 A FI923841 A FI 923841A FI 923841 A FI923841 A FI 923841A FI 101222 B1 FI101222 B1 FI 101222B1
Authority
FI
Finland
Prior art keywords
derivatives
ylmethoxyphenyl
quinolin
preparation
therapeutically active
Prior art date
Application number
FI923841A
Other languages
English (en)
Swedish (sv)
Other versions
FI923841A0 (fi
FI101222B (fi
FI923841A (fi
Inventor
Klaus-Helmut Mohrs
Siegfried Raddatz
Michael Matzke
Romanis Fruchtmann
Armin Hatzelmann
Christian Kohldorfer
Reiner Mueller-Peddinghaus
Pia Theisen-Popp
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI923841A0 publication Critical patent/FI923841A0/fi
Publication of FI923841A publication Critical patent/FI923841A/fi
Application granted granted Critical
Publication of FI101222B publication Critical patent/FI101222B/fi
Publication of FI101222B1 publication Critical patent/FI101222B1/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Measurement Of Force In General (AREA)
  • Sewage (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Moulding By Coating Moulds (AREA)
  • Vessels, Lead-In Wires, Accessory Apparatuses For Cathode-Ray Tubes (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Manufacture And Refinement Of Metals (AREA)
FI923841A 1991-08-29 1992-08-27 Menetelmä terapeuttisesti aktiivisten kinolin-2-yylimetoksifenyylijohdannaisten valmistamiseksi FI101222B1 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4128681A DE4128681A1 (de) 1991-08-29 1991-08-29 Substituierte mandelsaeurederivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE4128681 1991-08-29

Publications (4)

Publication Number Publication Date
FI923841A0 FI923841A0 (fi) 1992-08-27
FI923841A FI923841A (fi) 1993-03-01
FI101222B FI101222B (fi) 1998-05-15
FI101222B1 true FI101222B1 (fi) 1998-05-15

Family

ID=6439400

Family Applications (1)

Application Number Title Priority Date Filing Date
FI923841A FI101222B1 (fi) 1991-08-29 1992-08-27 Menetelmä terapeuttisesti aktiivisten kinolin-2-yylimetoksifenyylijohdannaisten valmistamiseksi

Country Status (21)

Country Link
US (1) US5292769A (fi)
EP (1) EP0529450B1 (fi)
JP (1) JPH05194402A (fi)
KR (1) KR930004270A (fi)
AT (1) ATE115949T1 (fi)
AU (1) AU643628B2 (fi)
CA (1) CA2076929A1 (fi)
CZ (1) CZ281501B6 (fi)
DE (2) DE4128681A1 (fi)
DK (1) DK0529450T3 (fi)
ES (1) ES2065737T3 (fi)
FI (1) FI101222B1 (fi)
GR (1) GR3015457T3 (fi)
HU (1) HU214577B (fi)
IL (1) IL102949A (fi)
MX (1) MX9204748A (fi)
MY (1) MY110206A (fi)
RU (1) RU2066315C1 (fi)
SK (1) SK263992A3 (fi)
TW (1) TW207995B (fi)
ZA (1) ZA926536B (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4219765A1 (de) * 1992-06-17 1993-12-23 Bayer Ag Substituierte (Benzothiazolyl- und Chinoxalyl-methoxy)phenylessigsäurederivate
US5512581A (en) * 1994-07-18 1996-04-30 Abbott Laboratories Iminoxycarboxylates and derivatives as inhibitors of leukotriene biosynthesis
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
DE4443891A1 (de) 1994-12-09 1996-06-13 Bayer Ag Heterocyclisch substituierte Oxy-phenyl-(phenyl)glycinolamide
US8719041B2 (en) * 2002-06-10 2014-05-06 Ebay Inc. Method and system for customizing a network-based transaction facility seller application
TW200410921A (en) * 2002-11-25 2004-07-01 Hoffmann La Roche Mandelic acid derivatives
AU2004298486A1 (en) 2003-12-12 2005-06-30 Wyeth Quinolines useful in treating cardiovascular disease
WO2008067566A1 (en) 2006-11-30 2008-06-05 Amira Pharmaceuticals, Inc. Compositions and treatments comprising 5-lipoxygenase-activating protein inhibitors and nitric oxide modulators
EP3102209B1 (en) 2014-02-04 2021-04-07 Bioscience Pharma Partners, LLC Use of flap inhibitors to reduce neuroinflammation mediated injury in the central nervous system

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3318145A1 (de) * 1983-05-18 1984-11-22 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3927931A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Disubstituierte (chinolin-2-yl-methoxy)phenylessigsaeure-derivate

Also Published As

Publication number Publication date
EP0529450A1 (de) 1993-03-03
US5292769A (en) 1994-03-08
CA2076929A1 (en) 1993-03-01
HUT67137A (en) 1995-02-28
ATE115949T1 (de) 1995-01-15
DE59201013D1 (de) 1995-02-02
SK279066B6 (sk) 1998-06-03
JPH05194402A (ja) 1993-08-03
RU2066315C1 (ru) 1996-09-10
EP0529450B1 (de) 1994-12-21
HU214577B (hu) 1998-04-28
HU9202780D0 (en) 1992-12-28
ES2065737T3 (es) 1995-02-16
ZA926536B (en) 1993-03-05
FI923841A0 (fi) 1992-08-27
KR930004270A (ko) 1993-03-22
IL102949A0 (en) 1993-01-31
IL102949A (en) 1997-02-18
AU643628B2 (en) 1993-11-18
SK263992A3 (en) 1998-06-03
FI101222B (fi) 1998-05-15
TW207995B (fi) 1993-06-21
CZ263992A3 (en) 1993-08-11
DK0529450T3 (da) 1995-05-15
GR3015457T3 (en) 1995-06-30
CZ281501B6 (cs) 1996-10-16
FI923841A (fi) 1993-03-01
AU2137192A (en) 1993-03-04
MX9204748A (es) 1993-02-01
DE4128681A1 (de) 1993-03-04
MY110206A (en) 1998-02-28

Similar Documents

Publication Publication Date Title
AU538424B2 (en) Piperazino phenylindane
AU548268B2 (en) 2-ammo-5-hydroxy-4-methylpyrimidinme derivatives
FI101222B1 (fi) Menetelmä terapeuttisesti aktiivisten kinolin-2-yylimetoksifenyylijohdannaisten valmistamiseksi
ES8308833A1 (es) "un metodo para la preparacion de 3-fenil-1-indanaminas".
IL106107A0 (en) Imidazolyl-substituted cyclohexane derivatives,their preparation and pharmaceutical compositions containing them
JPS5293755A (en) Preparation of carboxylic acid derivatives
JPS51144790A (en) Process for preparing l-cysteine derivatives
JPS5328161A (en) Preparation of 3-amino-1-benzylpyrrolidine derivatives
JPS523061A (en) Process for preparing 4-cyanoimidazole-5-carbamic acid esters
JPS5212194A (en) Process for preparing 2,7,1,3,6,8- dithiatetraaza-as-indacene
JPS5231093A (en) Preparation of 3- methylenecephalosporanic acid derivatives
JPS51127078A (en) A process for preparing beta-ethylenedioxy- phenyl propionic acid esters
JPS5268171A (en) Preparation of substituted ethyleneimines
JPS5253854A (en) Preparing optical active pyprolidine ethanols
JPS5379883A (en) Preparation of uracil
JPS51146442A (en) Process for preparing cyclopropanecarboxylic acid derivatives
JPS5246066A (en) Preparation of optically active 5-oxo-2-pyrrolipinyl acetic acid salts
JPS5225749A (en) Preparation of prostaglandin derivatives
JPS5246014A (en) Process for preparation of gamma-unsaturated carboxylic acid esters
JPS5233648A (en) Preparation of 3',4',-dideoxy-3',4',-didehydro-butyrosine derivatives